Partial splenic embolization for the treatment of hypersplenism in cirrhosis
Bruno Sangro, Ignacio Bilbao, Ignacio Herrero, Carmen Corella, Jesus Longo, Oscar Beloqui, Juan Ruiz, Jose M. Zozaya, Jorge Quirog, Jesus Priet – 1 August 1993 – Hypersplenism is of great relevance in the management of cirrhosis because of the widespread use of myelodepressant drugs such as interferon or antineoplastic agents. Because no standard therapy exists for this complication, we have evaluated the efficacy and risks of splenic embolization in the treatment of hypersplenism in cirrhosis.